Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Reference only. Not financial advice. No brokerage order is placed.
Independent agent review — valuation, statement audit, and earnings read on the latest filing.
QNRX is a micro-cap pharma filing a dilutive offering 10 weeks after a large binary catalyst spike that has already half-faded — the setup is structurally bearish for near-term holders and warrants a pass until offering terms and pipeline stage are confirmed.
Bull case: If the Aug-28 event was a pivotal trial success, the capital raise funds a registration-enabling trial or pre-NDA activities. A well-subscribed offering at or near market would signal institutional confidence in the pipeline, and a successful NDA filing could re-rate the stock toward the $7–8 range seen post-catalyst. The stock is trading close to its 6-month price floor ($3.25 all-time low hit Jun-23), limiting downside if the offering is modest.
Bear case: The stock has already surrendered 49% of its catalyst gains with no floor in sight; an offering priced at a 10–15% discount ($3.40–$3.60) would likely break the Jun-23 low of $3.25. Post-offering overhang from new shares suppresses any recovery. With zero news momentum, no moat score, and no visible institutional sponsorship, the offering may struggle to clear at terms favorable to existing holders. If the Aug-28 catalyst was not a pivotal readout (e.g., a partnership or interim data), the entire thesis is weaker than it appears.
| Date | List | Next-day max run | Next-day close | Hit +2%? |
|---|---|---|---|---|
| 2026-10-06 | sec_top_gappers | +2.3% | -0.4% | ✓ hit |
| 2026-10-06 | sec_top_moat_emerging | +2.3% | -0.4% | ✓ hit |
| 2026-10-05 | sec_top_gappers | +7.1% | +3.6% | ✓ hit |
| 2026-10-05 | sec_top_moat_emerging | +7.1% | +3.6% | ✓ hit |
| 2026-10-02 | sec_top_gappers | +6.0% | +1.9% | ✓ hit |
| 2026-10-02 | sec_top_moat_emerging | +6.0% | +1.9% | ✓ hit |
| 2026-09-25 | sec_top_gappers | -0.3% | -18.2% | — |
| 2026-09-25 | sec_top_moat_emerging | -0.3% | -18.2% | — |
| 2026-09-24 | sec_top_gappers | +4.9% | +0.8% | ✓ hit |
| 2026-09-24 | sec_top_moat_emerging | +4.9% | +0.8% | ✓ hit |
| 2026-09-23 | sec_top_gappers | +5.2% | -5.5% | ✓ hit |
| 2026-09-23 | sec_top_moat_emerging | +5.2% | -5.5% | ✓ hit |
No recent earnings event.
You came here for QNRX. You found it after it moved, the same way everyone else did.
Review the methodology and limitations and the dated audit. An intraday price touch is not trading profit.
One payment, access for as long as we run the service. The free daily picks stay free — this is for people who want the full console. Not buying today? Get tomorrow's ranked list free →